Evidence map›Paper›PMID 40365105›Full record

ArticleTurkish journal of biology = Turk biyoloji dergisi2025

Intrinsic apoptotic effect of Anatolian honeybee (

Batuhan Orman, Aylin Koç, Didem Şen Karaman, Ayşe Nalbantsoy

Abstract read
In one paragraph

Article in Turkish journal of biology = Turk biyoloji dergisi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Batuhan OrmanDepartment of Biotechnology, Graduate School of Natural and Applied Sciences, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-5773-7383
Aylin KoçDepartment of Biomedical Engineering, Graduate School of Natural and Applied Sciences, İzmir Kâtip Çelebi University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-3319-3641
Didem Şen KaramanDepartment of Biomedical Engineering, Faculty of Engineering and Architecture, İzmir Kâtip Çelebi University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-2368-9598
Ayşe NalbantsoyDepartment of Bioengineering, Faculty of Engineering, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-3852-1974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: The use of bee products or treatment with bees, as a complement to conventional medicine is attracting considerable attention in cancer research. Although discoveries related to the potential anticancer effects of bee venom are increasing, the unstable nature of venom biomolecules remains a limiting factor for their usage. In this study, we employed mesoporous silica nanocarriers (MSNs) to provide precise dosing and prevent carriers from biomolecule degradation thanks to the outstanding loading capacity provided by the pores, excellent chemical and biological robustness, and ability to improve bioavailability. Materials and methods: MSNs were synthesized and physicochemical characterizations were carried out. The cytotoxicity of Results: The MSNs exhibited significant cellular uptake of MSN by the PC3 and MDA-MB 231 cell lines, resulting in a 1.5-fold enhancement in the apoptotic effect of venom on the PC3 cell line when combined with MSNs, compared to cells exposed alone to venom. Conclusion: MSNs could effectively be taken up by MDA-MB 231 and PC3 cancer cells, enhancing the action of bee venom by the particle-mediated delivery. MSNs@Venom have the potential to offer cost-effective complementary and innovative cancer treatment options.

Indexed as

anticancer biomoleculeApis mellifera anatoliacaBee venommesoporous silica nanoparticles

Identifiers

PMID40365105
PMCPMC12068665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.